Alex Azar, the man who has been picked by US President Donald Trump for the position of Health and Human Services (HHS) secretary is known to have tripled the price of Insulin in his last stint as a high-ranking executive at the pharmaceutical company Eli Lily.
Azar is succeeding Tom Price who has to resign from the position of HHS secretary after the news of him using private and government planes at the cost of taxpayer money, came to light.
If Mr Azar becomes Health and Human Services secretary, he will be overseeing a £760bn department responsible for America’s major insurance programmes, including Obamacare, public health, medical research and food and drug safety.
Insulin is a life-saving drug that is used to treat diabetes.
Source: The Independent